Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts

Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.

[1]  J. Cauley.  Bone health after menopause , 2015, Current opinion in endocrinology, diabetes, and obesity.

[2]  P. Cawthon,et al.  Subclinical Thyroid Dysfunction and Frailty Among Older Men. , 2015, The Journal of clinical endocrinology and metabolism.

[3]  I. Reid.  Short-term and long-term effects of osteoporosis therapies , 2015, Nature Reviews Endocrinology.

[4]  A. Uitterlinden,et al.  Subclinical thyroid dysfunction and fracture risk: a meta-analysis. , 2015, JAMA.

[5]  L. Hegedüs,et al.  The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register‐Based Time‐Resolved Cohort Analysis , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[7]  J. Robbins,et al.  Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study. , 2014, The Journal of clinical endocrinology and metabolism.

[8]  B. Åsvold,et al.  Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. , 2013, European journal of endocrinology.

[9]  M. Lai,et al.  Effectiveness of Bisphosphonate Analogues and Functional Electrical Stimulation on Attenuating Post-Injury Osteoporosis in Spinal Cord Injury Patients- a Systematic Review and Meta-Analysis , 2013, PloS one.

[10]  M. Cooper,et al.  Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. , 2013, The lancet. Diabetes & endocrinology.

[11]  S. Bandinelli,et al.  Thyroid Status and 6‐Year Mortality in Elderly People Living in a Mildly Iodine‐Deficient Area: The Aging in the Chianti Area Study , 2013, Journal of the American Geriatrics Society.

[12]  P. Cawthon,et al.  A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  B. Biondi.  Natural history, diagnosis and management of subclinical thyroid dysfunction. , 2012, Best practice & research. Clinical endocrinology & metabolism.

[14]  J. Cauley,et al.  The effects of adiponectin and leptin on changes in bone mineral density , 2012, Osteoporosis International.

[15]  J. Franklyn,et al.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. , 2012, Archives of internal medicine.

[16]  V. Montori,et al.  Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  Soma Sh Abd El Gawad,et al.  Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men , 2011, BMC endocrine disorders.

[18]  D. Menzies.  Systematic reviews and meta-analyses. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  J. Franklyn,et al.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.

[20]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[21]  B. Biondi,et al.  The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.

[22]  A. Hofman,et al.  Effects of serum TSH and FT4 levels and the TSHR‐Asp727Glu polymorphism on bone: the Rotterdam Study , 2007, Clinical endocrinology.

[23]  R. Eastell,et al.  Risk Factors for Vertebral and Nonvertebral Fracture Over 10 Years: A Population‐Based Study in Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  K. Kaufman,et al.  The impact of overt and subclinical hyperthyroidism on skeletal muscle. , 2006, Thyroid : official journal of the American Thyroid Association.

[25]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[26]  A. Silman,et al.  Predictive Value of BMD for Hip and Other Fractures , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Mark C Simmonds,et al.  Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.

[28]  M. Helfand.  Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.

[29]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[30]  P. Vestergaard,et al.  Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. , 2003, Thyroid : official journal of the American Thyroid Association.

[31]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[32]  R. Klesges,et al.  A meta-analysis of the effects of cigarette smoking on bone mineral density , 2001, Calcified Tissue International.

[33]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[34]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[35]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[36]  L. Lix,et al.  Fracture prediction from repeat BMD measurements in clinical practice , 2015, Osteoporosis International.

[37]  B. A. Conway,et al.  The effects of laforin, malin, Stbd1, and Ptg deficiencies on heart glycogen levels in Pompe disease mouse models , 2015 .

[38]  J. Li,et al.  Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies , 2015, Osteoporosis International.

[39]  S. Barr,et al.  Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles. , 2014, Epidemiologic reviews.

[40]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[41]  B. D. da Costa,et al.  Systematic reviews and meta-analyses of randomized trials : principles and pitfalls , 2014 .

[42]  M. Schott.  Thyroid Function within the Upper Normal Range Is Associated with Reduced Bone Mineral Density and an Increased Risk of Nonvertebral Fractures in Healthy Euthyroid Postmenopausal Women , 2011 .

[43]  Z. Belaya,et al.  Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women. , 2007, Hormones.

[44]  D. Marchant,et al.  Risk factors. , 1994, Obstetrics and gynecology clinics of North America.